Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Murat Gokden to Immunohistochemistry

This is a "connection" page, showing publications Murat Gokden has written about Immunohistochemistry.

 
Connection Strength
  
 
 
1.613
  
  1. Brasher OC, Nix JS, Gokden M. Significance of Staining Intensity in Ki-67 Proliferation Index in Meningiomas, and a Critical Review of the Literature on Proliferation Index Assessment. Ann Clin Lab Sci. 2024 Mar; 54(2):170-178.
    View in: PubMed
    Score: 0.749
  2. Gokden N, Kemp SA, Gokden M. The utility of Pax-2 as an immunohistochemical marker for renal cell carcinoma in cytopathology. Diagn Cytopathol. 2008 Jul; 36(7):473-7.
    View in: PubMed
    Score: 0.253
  3. Gokden M. If it is Not a Glioblastoma, Then What is it? A Differential Diagnostic Review. Adv Anat Pathol. 2017 Nov; 24(6):379-391.
    View in: PubMed
    Score: 0.121
  4. Sharma SG, Gokden M, McKenney JK, Phan DC, Cox RM, Kelly T, Gokden N. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features. Appl Immunohistochem Mol Morphol. 2010 Dec; 18(6):494-8.
    View in: PubMed
    Score: 0.075
  5. Gokden N, Gokden M, Phan DC, McKenney JK. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker. Am J Surg Pathol. 2008 Oct; 32(10):1462-7.
    View in: PubMed
    Score: 0.064
  6. Cetin N, Dienel G, Gokden M. CD117 expression in glial tumors. J Neurooncol. 2005 Nov; 75(2):195-202.
    View in: PubMed
    Score: 0.053
  7. Gokden M, Shinde A. Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver. Diagn Cytopathol. 2005 Sep; 33(3):166-72.
    View in: PubMed
    Score: 0.052
  8. Gokden N, Mukunyadzi P, James JD, Gokden M. Diagnostic utility of renal cell carcinoma marker in cytopathology. Appl Immunohistochem Mol Morphol. 2003 Jun; 11(2):116-9.
    View in: PubMed
    Score: 0.044
  9. Perez I, Gokden M, Day JD, Yaziji H, Pina-Oviedo S. Primary histiocytic sarcoma of the clivus with focal extension into central nervous system and neurologic manifestations: First description at an unusual site with an overwhelming and rapid progression. Clin Neuropathol. 2022 Mar-Apr; 41(2):74-82.
    View in: PubMed
    Score: 0.041
  10. D'Almeida Costa F, Dias TM, Lombardo KA, Raghunathan A, Giannini C, Kenyon L, Saad AG, Gokden M, Burger PC, Montgomery EA, Rodriguez FJ. Intracranial cellular schwannomas: a clinicopathological study of 20 cases. Histopathology. 2020 Jan; 76(2):275-282.
    View in: PubMed
    Score: 0.035
  11. Gomez-Acevedo H, Patterson JD, Sardar S, Gokden M, Das BC, Ussery DW, Rodriguez A. SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion. BMC Cancer. 2019 Aug 22; 19(1):827.
    View in: PubMed
    Score: 0.034
  12. Phillips BC, Gokden M, Petersen E. Granulomatous encephalitis due to Balamuthia mandrillaris is not limited to immune-compromised patients. Clin Neurol Neurosurg. 2013 Jul; 115(7):1102-4.
    View in: PubMed
    Score: 0.021
  13. Scheithauer BW, Erdogan S, Rodriguez FJ, Burger PC, Woodruff JM, Kros JM, Gokden M, Spinner RJ. Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 cases. Am J Surg Pathol. 2009 Mar; 33(3):325-38.
    View in: PubMed
    Score: 0.017
  14. De Las Casas LE, Gokden M, Baker SJ, Korourian S, Hermonat PL, You H, Miranda RN, Shalkham JE, O'Brien LA, Mukunyadzi P. Malignant melanoma metastatic to the liver. A cytomorphologic comparative study to identify reproducible diagnostic criteria. Acta Cytol. 2004 Jan-Feb; 48(1):32-8.
    View in: PubMed
    Score: 0.012
  15. Bellone S, Palmieri M, Gokden M, Joshua J, Roman JJ, Pecorelli S, Cannon MJ, Santin AD. Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy. Gynecol Oncol. 2003 Oct; 91(1):231-40.
    View in: PubMed
    Score: 0.011
  16. Cetin N, Ball K, Gokden M, Cruz NF, Dienel GA. Effect of reactive cell density on net [2-14C]acetate uptake into rat brain: labeling of clusters containing GFAP+- and lectin+-immunoreactive cells. Neurochem Int. 2003 Apr; 42(5):359-74.
    View in: PubMed
    Score: 0.011
  17. Hameed A, Gokden M, Hanna EY. Fine-needle aspiration cytology of a primary ectopic meningioma. Diagn Cytopathol. 2002 May; 26(5):297-300.
    View in: PubMed
    Score: 0.010
  18. Santin AD, Bellone S, Gokden M, Palmieri M, Dunn D, Agha J, Roman JJ, Hutchins L, Pecorelli S, O'Brien T, Cannon MJ, Parham GP. Overexpression of HER-2/neu in uterine serous papillary cancer. Clin Cancer Res. 2002 May; 8(5):1271-9.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.